-
AstraZeneca’s Imfinzi gets speedy US review for lung cancer
- Source: Pharmatimes
- 787
- October 18, 2017
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
